These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 26820487

  • 1. Benefits of Using CD45RA and CD28 to Investigate CD8 Subsets in Kidney Transplant Recipients.
    Yap M, Tilly G, Giral M, Brouard S, Degauque N.
    Am J Transplant; 2016 Mar; 16(3):999-1006. PubMed ID: 26820487
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
    Tomiyama H, Matsuda T, Takiguchi M.
    J Immunol; 2002 Jun 01; 168(11):5538-50. PubMed ID: 12023349
    [Abstract] [Full Text] [Related]

  • 3. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
    Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N.
    J Immunol; 2007 Apr 01; 178(7):4112-9. PubMed ID: 17371966
    [Abstract] [Full Text] [Related]

  • 4. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H, Takiguchi M.
    J Immunol; 2006 Oct 01; 177(7):4330-40. PubMed ID: 16982867
    [Abstract] [Full Text] [Related]

  • 5. Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression.
    Monteiro M, Evaristo C, Legrand A, Nicoletti A, Rocha B.
    Blood; 2007 Apr 01; 109(7):2863-70. PubMed ID: 17148588
    [Abstract] [Full Text] [Related]

  • 6. Effector Memory-Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory Responses.
    Doan Ngoc TM, Tilly G, Danger R, Bonizec O, Masset C, Guérif P, Bruneau S, Glemain A, Harb J, Cadoux M, Vivet A, Mai HL, Garcia A, Laplaud D, Liblau R, Giral M, Blandin S, Feyeux M, Dubreuil L, Pecqueur C, Cyr M, Ni W, Brouard S, Degauque N, on behalf on the DIVAT Consortium, DIVAT Consortium.
    J Am Soc Nephrol; 2022 Dec 01; 33(12):2211-2231. PubMed ID: 36280286
    [Abstract] [Full Text] [Related]

  • 7. Phenotype and molecular signature of CD8+ T cell subsets in T cell- mediated rejections after kidney transplantation.
    Ko EJ, Seo JW, Kim KW, Kim BM, Cho JH, Kim CD, Seok J, Yang CW, Lee SH, Chung BH.
    PLoS One; 2020 Dec 01; 15(6):e0234323. PubMed ID: 32530943
    [Abstract] [Full Text] [Related]

  • 8. Increased Pretransplant Frequency of CD28+ CD4+ TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients.
    Cortes-Cerisuelo M, Laurie SJ, Mathews DV, Winterberg PD, Larsen CP, Adams AB, Ford ML.
    Am J Transplant; 2017 Sep 01; 17(9):2350-2362. PubMed ID: 28502091
    [Abstract] [Full Text] [Related]

  • 9. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
    Xu H, Samy KP, Guasch A, Mead SI, Ghali A, Mehta A, Stempora L, Kirk AD.
    Am J Transplant; 2016 Feb 01; 16(2):550-64. PubMed ID: 26436448
    [Abstract] [Full Text] [Related]

  • 10. Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8+ T Cells, Impairing Cytotoxic Mechanisms After Kidney Transplantation.
    Leonhard J, Schaier M, Kälble F, Eckstein V, Zeier M, Steinborn A.
    Front Immunol; 2022 Feb 01; 13():752570. PubMed ID: 35592311
    [Abstract] [Full Text] [Related]

  • 11. Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division.
    Hamann D, Kostense S, Wolthers KC, Otto SA, Baars PA, Miedema F, van Lier RA.
    Int Immunol; 1999 Jul 01; 11(7):1027-33. PubMed ID: 10383934
    [Abstract] [Full Text] [Related]

  • 12. CD45RA expression on HCMV-specific effector memory CD8+ T cells is associated with the duration and intensity of HCMV replication after transplantation.
    Cantisán S, Solana R, Lara R, Rodríguez-Benot A, Vaquero JM, Gutiérrez-Aroca J, Gayoso I, Montejo M, Rivero A, Torre-Cisneros J.
    Clin Immunol; 2010 Oct 01; 137(1):81-8. PubMed ID: 20674505
    [Abstract] [Full Text] [Related]

  • 13. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
    Tsukishiro T, Donnenberg AD, Whiteside TL.
    Cancer Immunol Immunother; 2003 Oct 01; 52(10):599-607. PubMed ID: 12827303
    [Abstract] [Full Text] [Related]

  • 14. Age-associated changes in the frequency of naïve, memory and effector CD8+ T cells.
    Hong MS, Dan JM, Choi JY, Kang I.
    Mech Ageing Dev; 2004 Sep 01; 125(9):615-8. PubMed ID: 15491679
    [Abstract] [Full Text] [Related]

  • 15. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells.
    Fukada K, Sobao Y, Tomiyama H, Oka S, Takiguchi M.
    J Immunol; 2002 Mar 01; 168(5):2225-32. PubMed ID: 11859109
    [Abstract] [Full Text] [Related]

  • 16. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
    Betjes MGH, Litjens NHR.
    PLoS One; 2020 Mar 01; 15(2):e0228096. PubMed ID: 32023273
    [Abstract] [Full Text] [Related]

  • 17. Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.
    Yap M, Boeffard F, Clave E, Pallier A, Danger R, Giral M, Dantal J, Foucher Y, Guillot-Gueguen C, Toubert A, Soulillou JP, Brouard S, Degauque N.
    J Am Soc Nephrol; 2014 Aug 01; 25(8):1856-68. PubMed ID: 24652799
    [Abstract] [Full Text] [Related]

  • 18. Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.
    Mathews DV, Wakwe WC, Kim SC, Lowe MC, Breeden C, Roberts ME, Farris AB, Strobert EA, Jenkins JB, Larsen CP, Ford ML, Townsend R, Adams AB.
    Am J Transplant; 2017 Sep 01; 17(9):2285-2299. PubMed ID: 28502128
    [Abstract] [Full Text] [Related]

  • 19. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
    Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R.
    Clin Diagn Lab Immunol; 1995 Mar 01; 2(2):249-52. PubMed ID: 7697540
    [Abstract] [Full Text] [Related]

  • 20. Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
    Pender MP, Csurhes PA, Pfluger CM, Burrows SR.
    Mult Scler; 2014 Dec 01; 20(14):1825-32. PubMed ID: 24842963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.